IRIS
GALLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.487
NA - Nord America 1.861
EU - Europa 777
SA - Sud America 253
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 39
OC - Oceania 4
Totale 8.480
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.101
US - Stati Uniti d'America 1.768
CN - Cina 543
IT - Italia 438
BD - Bangladesh 323
HK - Hong Kong 242
BR - Brasile 167
VN - Vietnam 111
FR - Francia 83
GB - Regno Unito 72
DE - Germania 43
IN - India 38
MX - Messico 38
CA - Canada 32
NL - Olanda 31
AR - Argentina 28
ID - Indonesia 20
FI - Finlandia 16
CZ - Repubblica Ceca 15
PL - Polonia 15
UA - Ucraina 15
ZA - Sudafrica 15
EC - Ecuador 14
TR - Turchia 13
CO - Colombia 12
MY - Malesia 12
PK - Pakistan 10
SA - Arabia Saudita 10
CL - Cile 9
VE - Venezuela 9
RU - Federazione Russa 8
ES - Italia 7
PH - Filippine 7
JM - Giamaica 6
JP - Giappone 6
SE - Svezia 6
UY - Uruguay 6
CH - Svizzera 5
HN - Honduras 5
IQ - Iraq 5
KE - Kenya 5
PY - Paraguay 5
AT - Austria 4
AZ - Azerbaigian 4
BY - Bielorussia 4
CR - Costa Rica 4
IE - Irlanda 4
KR - Corea 4
LB - Libano 4
NP - Nepal 4
AU - Australia 3
BE - Belgio 3
BH - Bahrain 3
CY - Cipro 3
HU - Ungheria 3
KZ - Kazakistan 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
JO - Giordania 2
KH - Cambogia 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BJ - Benin 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GN - Guinea 1
GT - Guatemala 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
SO - Somalia 1
TH - Thailandia 1
TL - Timor Orientale 1
TW - Taiwan 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 8.422
Salva come PNG Salva come JPEG
Città #
San Jose 478
Singapore 373
Ashburn 299
Rome 261
Hong Kong 236
Hefei 160
Beijing 157
Council Bluffs 98
Columbus 86
Dallas 82
Lauterbourg 73
Shanghai 69
Santa Clara 64
Boardman 61
New York 51
Ho Chi Minh City 41
Los Angeles 39
London 38
Mexico City 26
Hanoi 25
Buffalo 24
São Paulo 20
Amsterdam 17
Munich 17
San Francisco 16
Brno 15
Seattle 15
Phoenix 12
Toronto 12
Turku 12
Warsaw 12
Orem 11
Boston 10
Manchester 9
Milan 9
Bologna 8
Charlotte 8
Chennai 8
Haiphong 8
Pune 8
Rio de Janeiro 8
Atlanta 7
Brooklyn 7
Chicago 7
Guangzhou 7
Johannesburg 7
Las Vegas 7
Pasadena 7
Da Nang 6
Guayaquil 6
Montreal 6
Washington 6
Bari 5
Brownsville 5
Frankfurt am Main 5
Lahore 5
Naples 5
Tokyo 5
Bogotá 4
Brasília 4
Brescia 4
Helsinki 4
Kuala Lumpur 4
Miami 4
Montevideo 4
Nairobi 4
New Delhi 4
Palermo 4
Paris 4
Philadelphia 4
Stockholm 4
Turin 4
Verona 4
Acalanes Ridge 3
Baku 3
Barquisimeto 3
Canberra 3
Catania 3
City of London 3
Denver 3
Helena 3
Houston 3
Istanbul 3
Krasnodar 3
Manama 3
Manaus 3
Medellín 3
Minsk 3
Mumbai 3
Poplar 3
Ribeirão Preto 3
Riyadh 3
Thái Nguyên 3
Vienna 3
Zurich 3
Arayat 2
Ashland 2
Augusta 2
Bekasi 2
Belo Horizonte 2
Totale 3.215
Salva come PNG Salva come JPEG
Nome #
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 255
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 252
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 239
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 237
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 237
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 235
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 231
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 220
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 218
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 217
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 216
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 212
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 211
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 203
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 202
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 201
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 179
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 147
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 143
A challenging alfa-fetoprotein in a cirrhotic patient 136
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 134
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 127
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 122
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 119
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 117
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 117
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 116
ALT levels are associated with metabolic parameters and age in a large real-life population. 115
Pain and Frailty in Hospitalized Older Adults 109
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 107
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 106
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 97
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 97
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 96
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 93
Sarcopenia in Chronic Liver Disease: The Emerging Role of Ultrasound in Determining Muscle Mass, Strength and Clinical Outcomes 91
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 90
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 86
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 83
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 80
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 78
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 75
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 74
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 74
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 73
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 70
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 70
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 68
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 68
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 67
Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study 63
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 62
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 61
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 58
What changed in the Italian internal medicine and geriatric wards during the lockdown 57
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 55
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 52
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 52
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 52
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 51
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 49
Renal impairment and anemia during triple therapy 48
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 48
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 48
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 48
Decoding the molecular and genomic landscape of hepatocellular carcinoma: biomarker discovery, classification frameworks, and therapeutic targeting 47
Steroid-refractory immune related hepatitis may hide viral re-activation 47
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 45
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 44
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 43
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 42
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 41
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 41
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 40
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 40
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 39
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 38
Editorial: Clinical management of older persons with sarcopenia: current status and future directions 37
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 34
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 33
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 32
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease 23
Totale 8.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202290 0 0 2 0 1 0 2 2 12 0 2 69
2022/202319 0 0 0 0 1 2 5 1 1 3 6 0
2023/2024176 6 14 4 23 13 78 2 6 3 6 5 16
2024/20254.457 38 16 66 12 129 98 77 14 176 263 1.749 1.819
2025/20263.333 243 156 192 300 135 156 779 165 216 289 365 337
2026/2027405 54 292 59 0 0 0 0 0 0 0 0 0
Totale 8.480